Share:
Share this content in WeChat
X
Case Report
A case of low-grade malignant myofibroblastic sarcoma of chest wall
YANG Wengang  ZHU Dalin  HAN Hongying  HE Wanli 

Cite this article as: YANG W G, ZHU D L, HAN H Y, et al. A case of low-grade malignant myofibroblastic sarcoma of chest wall[J]. Chin J Magn Reson Imaging, 2023, 14(7): 127-128, 138. DOI:10.12015/issn.1674-8034.2023.07.022.


[Keywords] myofibroblastic sarcoma;chest wall;magnetic resonance imaging;pathology;case report

YANG Wengang   ZHU Dalin   HAN Hongying*   HE Wanli  

Medical Imaging Center, Gansu Province Maternal and Child Care Service Center, Lanzhou 730050, China

Corresponding author: Han HY, E-mail: 1150371476@qq.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Natural Science Foundation of Gansu Province (No. 21JR11RA170).
Received  2023-02-04
Accepted  2023-05-18
DOI: 10.12015/issn.1674-8034.2023.07.022
Cite this article as: YANG W G, ZHU D L, HAN H Y, et al. A case of low-grade malignant myofibroblastic sarcoma of chest wall[J]. Chin J Magn Reson Imaging, 2023, 14(7): 127-128, 138. DOI:10.12015/issn.1674-8034.2023.07.022.

[1]
WANG S, ZHU H L, WANG H J, et al. Low-grade malignant myofibroblastic sarcoma of left thigh recurred three times: a case report[J]. Clin J Med Off, 2022, 50(6): 655- 657. DOI: 10.16680/j.1671-3826.2022.06.32.
[2]
MIKAMI Y, FUJII S, KOHASHI K I, et al. Low-grade myofibroblastic sarcoma arising in the tip of the tongue with intravascular invasion: a case report[J]. Oncol Lett, 2018, 16(3): 3889-3894. DOI: 10.3892/ol.2018.9115.
[3]
WANG L, LI L X, CHEN D Q, et al. Low-grade Myofibroblastic sarcoma: clinical and imaging findings[J].BMC Med Imaging, 2019, 19(1): 1-9. DOI: 10.1186/s12880-018-0287-z.
[4]
CHAN J Y, GOOI Z, WONG E W, et al. Low-grade myofibroblastic sarcoma: a population-based study[J]. Laryngoscope, 2017, 127(1): 116-121. DOI: 10.1002/lary.26146.
[5]
YU Y H, HE G L, CHEN B. Imaging manifestations and misdiagnosis analysis of low-grade malignant myofibroblastic sarcoma[J]. Zhejiang Clin Med J, 2016, 18(4): 747-748. DOI: 10.3969/j.issn.1005-5185.2014.05.010
[6]
ZHANG W W, XU Y K. Imaging findings of low-grade myofibroblastic sarcoma[J]. Chin J Med Imaging Technol, 2012, 28(8): 1591-1595. DOI: 10.3969/j.issn.1673-2588.2011.10.005
[7]
YU Y M, CAO C Y, LIU X M. Diagnostic value of CT and MRI in the abdominal aggressive fibromatosis[J]. J Med Imaging, 2019, 29(7): 1163-1166. DOI: 10.3969/j.issn.1005-5185.2017.09.008
[8]
DUAN S J, ZHU X F, LEI X B. Diagnostic value of HRCT and MRI of desmoid fibromatosis in chest wall[J]. Radiol Pract, 2021, 36(12)1509-1513. DOI: 10.13609/j.cnki.1000-0313.2021.12.010
[9]
LOYA A, RAMACHANDRAN V, PHAN K. Second primary malignancies after initial cutaneous pleomorphic sarcoma: a national database study[J]. J Am Acad Dermatol, 2020, 83(2): e125-e127. DOI: 10.1016/j.jaad.2019.08.036.
[10]
DICKIE C, PARENT A, CHUNG P, et al. SP-0115: adaptive treatment planning in soft tissue sarcoma: why and when is it necessary?[J]. Radiother Oncol, 2015, 115: S54-S55. DOI: 10.1016/s0167-8140(15)40113-6.
[11]
KELATI A, MERNISSI F Z. The rainbow pattern in dermoscopy: a zoom on nonkaposi sarcoma skin diseases[J]. Biomed J, 2018, 41(3): 209-210. DOI: 10.1016/j.bj.2018.04.004.

PREV Research on the method of brain magnetic resonance synthetic DWI generation based on the cycle generative adversarial network
NEXT Research progress of magnetic resonance cerebral perfusion imaging in Alzheimer,s disease
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn